TABLE 3.
Age-standardized mortality rate and the Joinpoint results in AD and other dementias by gender, residence, and region (China, 2011–2020).
| National | Urban | Rural | Eastern | Central | Western | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | Male | Female | All | Male | Female | All | Male | Female | All | Male | Female | All | Male | Female | All | Male | Female | |
| 2011 | 4.99 | 5.38 | 4.69 | 4.52 | 4.80 | 4.29 | 5.27 | 5.77 | 4.91 | 5.50 | 5.80 | 5.25 | 4.42 | 5.03 | 4.02 | 4.69 | 5.08 | 4.35 |
| 2012 | 3.88 | 4.03 | 3.74 | 3.27 | 3.21 | 3.31 | 4.29 | 4.64 | 4.00 | 4.53 | 4.67 | 4.40 | 3.50 | 3.81 | 3.24 | 3.14 | 3.21 | 3.05 |
| 2013 | 4.05 | 4.12 | 3.95 | 3.48 | 3.49 | 3.44 | 4.34 | 4.44 | 4.21 | 5.07 | 5.02 | 5.05 | 3.29 | 3.56 | 3.03 | 3.03 | 3.18 | 2.90 |
| 2014 | 3.96 | 4.06 | 3.81 | 3.67 | 3.68 | 3.60 | 4.09 | 4.24 | 3.91 | 5.02 | 5.10 | 4.88 | 3.00 | 3.12 | 2.84 | 3.14 | 3.38 | 2.89 |
| 2015 | 3.91 | 3.97 | 3.80 | 3.59 | 3.72 | 3.45 | 4.06 | 4.09 | 3.97 | 5.05 | 4.97 | 5.03 | 2.68 | 2.85 | 2.51 | 3.41 | 3.65 | 3.18 |
| 2016 | 3.92 | 3.97 | 3.82 | 3.59 | 3.62 | 3.53 | 4.07 | 4.15 | 3.96 | 5.00 | 5.05 | 4.89 | 2.58 | 2.71 | 2.43 | 3.72 | 3.79 | 3.62 |
| 2017 | 3.99 | 4.15 | 3.81 | 3.71 | 3.84 | 3.58 | 4.12 | 4.30 | 3.92 | 4.88 | 5.04 | 4.70 | 2.88 | 3.14 | 2.64 | 3.74 | 3.87 | 3.61 |
| 2018 | 4.01 | 4.06 | 3.93 | 3.75 | 3.72 | 3.75 | 4.14 | 4.24 | 4.02 | 4.66 | 4.64 | 4.62 | 3.19 | 3.35 | 3.03 | 3.87 | 3.96 | 3.76 |
| 2019 | 4.57 | 4.57 | 4.53 | 4.05 | 4.08 | 4.01 | 4.86 | 4.86 | 4.82 | 5.07 | 4.92 | 5.14 | 4.00 | 4.15 | 3.86 | 4.36 | 4.49 | 4.23 |
| 2020 | 4.10 | 4.19 | 3.99 | 3.52 | 3.48 | 3.51 | 4.45 | 4.64 | 4.27 | 4.79 | 4.80 | 4.73 | 3.28 | 3.38 | 3.18 | 3.88 | 4.16 | 3.63 |
| APC (95% CI) | −0.4 (−2.5–1.8) | −0.8 (−3.2–1.6) | −0.1 (−2.2–2.1) | −0.2 (−2.6–2.2) | −0.5 (−3.3–2.4) | 0 (−2.1–2.1) | −0.5 (−2.8–1.8) | 2011–2014 −10* (−17.4–1.9) | −0.1 (−2.4–2.2) | −0.6 (−1.9–0.8) | −1.1 (−2.5–0.4) | −0.3 (−1.7–1.2) | 2011–2015 −11.6* (−21.0–1.1) | 2011–2015 −12.8* (−22.4–2.0) | 2011–2015 −11.2* (−20.8–0.3) | 2011–2013 −17.7 (−29.0–4.6) | 2011–2013 19.1* (−6.9-52.2) | 2011–2013 −16.6 (−37–10.4) |
| 2014–2020 2.6 (−0.4–5.6) | 2015–2020 7.2 (−1.0–16.1) | 2015–2020 6.9 (−1.6–16.1) | 2015–2020 7.8 (−0.6–17.0) | 2013–2020 5.1* (3.0–7.2) | 2013–2020 3.0* (1.5–4.6) | 2013–2020 5.4* (1.5–9.4) | ||||||||||||
| p-value | 0.693 | 0.453 | 0.934 | 0.844 | 0.708 | 0.992 | 0.618 | 0.025 0.074 | 0.916 | 0.347 | 0.126 | 0.681 | 0.037 0.076 | 0.029 0.094 | 0.046 0.064 | 0.068 0.005 | 0.019 0.001 | 0.157 0.016 |
| AAPC (95%CI) | −0.4 (−2.5–1.8) | −0.8 (−3.2–1.6) | −0.1 (−2.2–2.1) | −0.2 (−2.6–2.2) | −0.5 (−3.3–2.4) | 0 (−2.1–2.1) | −0.5 (−2.8–1.8) | −1.8 (−4.4–0.8) | −0.1 (−2.4–2.2) | −0.6 (−1.9–0.8) | −1.1 (−2.5–0.4) | −0.3 (−1.7–1.2) | −1.6 (−6.5–3.5) | −2.4 (−7.4–2.9) | −1.1 (−6.1–4.2) | −0.2 (−4.0–3.7) | −0.5 (−3.2–2.3) | 0 (−5.1–5.4) |
| p-value | 0.693 | 0.453 | 0.934 | 0.844 | 0.708 | 0.992 | 0.618 | 0.178 | 0.916 | 0.347 | 0.126 | 0.681 | 0.53 | 0.369 | 0.684 | 0.916 | 0.74 | 0.995 |
*Significantly different from zero at the alpha = 0.05 level. (p < 0.05).
AD, Alzheimer’s Disease; APC, annual percent change; AAPC, average annual percent change; CI, confidence interval.